Dynavax
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Dynavax and other ETFs, options, and stocks.About DVAX
Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older.
DVAX Key Statistics
Stock Snapshot
Dynavax(DVAX) stock is priced at $11.06, giving the company a market capitalization of 1.3B. It carries a P/E multiple of -28.96.
As of 2025-11-15, Dynavax(DVAX) stock has fluctuated between $11.03 and $11.24. The current price stands at $11.06, placing the stock +0.3% above today's low and -1.6% off the high.
The Dynavax(DVAX)'s current trading volume is 1.28M, compared to an average daily volume of 2.19M.
In the last year, Dynavax(DVAX) shares hit a 52-week high of $14.63 and a 52-week low of $9.20.
In the last year, Dynavax(DVAX) shares hit a 52-week high of $14.63 and a 52-week low of $9.20.
DVAX News
Dynavax Technologies Corporation recently announced an exclusive worldwide license agreement with Vaxart for the development and commercialization of Vaxart's o...
